November 4th is the day for FDA decisionnot November 5th, as Brokeinvestor posted (is there a pattern there?)
News Release from 10/26/2009 12:02 PM - Canada NewsWire
MISSISSAUGA, ON, Oct. 26, 2009 (Canada NewsWire via COMTEX News Network) --
Nuvo Research Inc. (TSX:NRI), today responded to a request from the Investment Industry Regulatory Organization of Canada (IIROC) on behalf of the Toronto Stock Exchange following recent trading activity of Nuvo shares.
While it is Nuvo's policy not to comment on market rumours or speculation, at the request of IIROC, Nuvo is confirming that, as previously disclosed, it anticipates receiving a decision from the United States Food and Drug Administration (FDA) on or about November 4, 2009 pertaining to the approvability of the Company's lead drug Pennsaid(R).
More food for thought for those holding longterm: which comes first - the reverse-split or buy-out?
Caveat emptor,
CJ